Diet-microbiome interactions enhance cancer immunotherapy in obesity.

Diet-dependent remodeling of the gut microbiome enhances anti-tumor immunity and may explain improved immune checkpoint blockade efficacy in obesity.

• Why it matters: Understanding how diet influences the gut microbiome and immune response is crucial for developing strategies to improve cancer immunotherapy outcomes, especially in obese individuals.
• What they did: Desharnais and colleagues analyzed the effects of dietary interventions on the gut microbiome and immune response, linking these changes to enhanced anti-tumor immunity in obesity.
• The result: Their findings suggest that dietary modulation of the microbiome could be a promising approach to optimize host conditions for more effective cancer immunotherapy.